Eversept Partners, LP Merus N.V. Transaction History

Eversept Partners, LP

$1.26 Billion
Q3 2024

A detailed history of Eversept Partners, LP transactions in Merus N.V. stock. As of the latest transaction made, Eversept Partners, LP holds 68,258 shares of MRUS stock, worth $3.39 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

68,258

Previous 66,474 2.68%

Holding current value

$3.39 Million

Previous $3.93 Million 13.3%

% of portfolio

0.27%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $84,186 - $104,970	1,784 Added 2.68%	68,258 $3.41 Million
Q2 2024 Aug 14, 2024	SELL	$39.81 - $60.2 $2.11 Million - $3.19 Million	-53,008 Reduced 44.36%	66,474 $3.93 Million
Q1 2024 May 15, 2024	BUY	$28.03 - $51.82 $105,280 - $194,635	3,756 Added 3.25%	119,482 $5.38 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $366,777 - $524,019	-18,284 Reduced 13.64%	115,726 $3.18 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $56,041 - $75,975	2,784 Added 2.12%	134,010 $3.16 Million
Q2 2023 Nov 08, 2023	BUY	$18.33 - $27.18 $39,776 - $58,980	2,170 Added 1.68%	131,226 $3.46 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $39,776 - $58,980	2,170 Added 1.68%	131,226 $3.46 Million
Q1 2023 Nov 08, 2023	SELL	$14.25 - $20.5 $790,875 - $1.14 Million	-55,500 Reduced 30.07%	129,056 $2.37 Million
Q1 2023 May 15, 2023	SELL	$14.25 - $20.5 $790,875 - $1.14 Million	-55,500 Reduced 30.07%	129,056 $2.37 Million
Q4 2022 Nov 08, 2023	SELL	$12.8 - $23.66 $1.18 Million - $2.18 Million	-92,117 Reduced 33.29%	184,556 $2.86 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $1.18 Million - $2.18 Million	-92,117 Reduced 33.29%	184,556 $2.86 Million
Q3 2022 Nov 08, 2023	SELL	$18.64 - $28.93 $207,519 - $322,077	-11,133 Reduced 3.87%	276,673 $5.54 Million
Q3 2022 Nov 14, 2022	SELL	$18.64 - $28.93 $207,519 - $322,077	-11,133 Reduced 3.87%	276,673 $5.54 Million
Q2 2022 Nov 08, 2023	BUY	$13.98 - $29.25 $2.95 Million - $6.17 Million	210,957 Added 274.51%	287,806 $6.52 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $2.95 Million - $6.17 Million	210,957 Added 274.51%	287,806 $6.52 Million
Q1 2022 Nov 08, 2023	SELL	$23.58 - $30.91 $1.28 Million - $1.68 Million	-54,377 Reduced 41.44%	76,849 $2.03 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $1.36 Million - $1.79 Million	57,849 Added 304.47%	76,849 $2.03 Million
Q4 2021 Nov 08, 2023	BUY	$20.0 - $32.29 $91,100 - $147,080	4,555 Added 31.53%	19,000 $604,000
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $380,000 - $613,510	19,000 New	19,000 $604,000
Q1 2021 May 13, 2021	SELL	$16.14 - $29.11 $233,142 - $420,493	-14,445 Closed	0 $0
Q4 2020 Nov 08, 2023	SELL	$11.4 - $18.36 $1.33 Million - $2.14 Million	-116,781 Reduced 88.99%	14,445 $253,000
Q4 2020 Feb 16, 2021	BUY	$11.4 - $18.36 $164,673 - $265,210	14,445 New	14,445 $253,000

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Account

Eversept Partners, LP Merus N.V. Transaction History